This marks my tenth January as an investor. A new year always comes with lots…
Entrepreneurship
Part of the job of a VC is to deliver on the promises they made to investors when raising the fund. Every VC defines their investment scope by a combination of thesis (e.g. invest in network-effect driven business), thematic interest (e.g. invest in AR / VR companies), stage (single stage versus lifecycle investment), ownership targets, […]
This marks my tenth January as an investor. A new year always comes with lots…
Long-term partner Acton Capital (for whom I act as a venture partner for North-America) has…
Part of the job of a VC is to deliver on the promises they made to investors when raising the fund. Every VC defines their investment scope by a combination of thesis (e.g. invest in network-effect driven business), thematic interest (e.g. invest in AR / VR companies), stage (single stage versus lifecycle investment), ownership targets, and geography.
For example, our sweet spot at V1 is to invest in early-stage companies and platforms that leverage network effects and are based in North-America. When we’re pitched with opportunities that are outside this focus, it’s usually a quick no.
This is why it’s so important for entrepreneurs to do their research beforehand and identify a short list of target investors – these will be the investors who will not only be a perfect fit for you, but where there’s also a decent possibility of closing.
If you’re raising a seed round, don’t target a firm that primarily focuses on later rounds. If you are a healthcare startup, you shouldn’t waste your time pitching a firm who’s primarily focused on AR right now. Mark Suster wrote a great post outlining some of the basic research you should do before starting your fundraising.
With all that said, there are times when VCs may deviate from their investment focus. Such exceptions are rare, but they happen. That’s what happened when we invested in Coinbase’s Series D last year.
What will compel a VC to stray so far from their sweet spot? Making an exception is a signifcant risk and is a lot harder to explain to investors should the deal go south.
In the case of Coinbase, we had a pretty strong conviction based on several factors:
Investors are going to limit their exceptions to truly special opportunities. We think Coinbase was and is one of these opportunities and eight months into the investment, we feel very good about the decision we made. But as an entrepreneur, you need to keep in mind that such exceptions are few and far between. It’s much better to do your research upfront and focus on those investors who are the right fit.
Health / Biology, Portfolio, Version One
Shifting healthcare systems from reactive to proactive care is critical – the best outcomes occur when people can take action early, before a condition becomes a diagnosis. That’s why we are excited to announce that we have led a $2.5m pre-seed round for NiaHealth and are thrilled that they are coming out of stealth and […]
We are continually refining our thesis on healthcare, from looking at clinical-grade at-home diagnostics to biotech and…
Over the past year, some of the most interesting and intellectually-stimulating pitches we heard have…